Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

NCT05995600 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Antiphospholipid Syndrome
Ischemic Stroke
Transient Ischemic Attack
Cerebrovascular Disease
Cardiovascular Diseases
Major Bleed

Interventions

DRUG: Antiplatelet Drug
DRUG: Warfarin

Sponsor

Seoul National University Hospital

Collaborators

[object Object]